New data from Ahmed et al. show that discharge prescriptions for renin-angiotensin-aldosterone inhibitor therapy are associated with a significant reduction in all-cause mortality in elderly patients with diastolic heart failure and chronic kidney disease (CKD). These observational data support the case for prospective studies of RAAS blockade in patients with CKD and diastolic heart failure. Franssen, C. F. M. & Navis, G. Nat. Rev. Nephrol. 9, 190-192 (2013); published online 12 March 2013; doi:10.1038/nrneph.2013.39</p
Chronic kidney disease (CKD) is increasingly prevalent in patients with heart failure (HF) and HF is...
International audienceOBJECTIVES: Renin-angiotensin system inhibitors (RASi) are recommended for slo...
The renin angiotensin aldosterone system (RAAS) has a key role in the regulation of blood pressure, ...
New data from Ahmed et al. show that discharge prescriptions for renin-angiotensin-aldosterone inhib...
AbstractIn clinical setting, congestive heart failure (CHF) and chronic kidney disease (CKD) often c...
In clinical setting, congestive heart failure (CHF) and chronic kidney disease (CKD) often co-exist ...
Abstract: The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic ...
Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of ...
Abstract Background Chronic kidney disease (CKD) is a leading cause of death before and after onset ...
Chronic kidney disease has serious implications with a high risk for progressive loss of renal funct...
I Reduction of blood pressure and proteinuria by blockade of the renin-angiotensin-aldosterone syste...
Chronic kidney disease (CKD) is increasingly prevalent in patients with heart failure (HF) and HF is...
International audienceOBJECTIVES: Renin-angiotensin system inhibitors (RASi) are recommended for slo...
The renin angiotensin aldosterone system (RAAS) has a key role in the regulation of blood pressure, ...
New data from Ahmed et al. show that discharge prescriptions for renin-angiotensin-aldosterone inhib...
AbstractIn clinical setting, congestive heart failure (CHF) and chronic kidney disease (CKD) often c...
In clinical setting, congestive heart failure (CHF) and chronic kidney disease (CKD) often co-exist ...
Abstract: The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic ...
Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of ...
Abstract Background Chronic kidney disease (CKD) is a leading cause of death before and after onset ...
Chronic kidney disease has serious implications with a high risk for progressive loss of renal funct...
I Reduction of blood pressure and proteinuria by blockade of the renin-angiotensin-aldosterone syste...
Chronic kidney disease (CKD) is increasingly prevalent in patients with heart failure (HF) and HF is...
International audienceOBJECTIVES: Renin-angiotensin system inhibitors (RASi) are recommended for slo...
The renin angiotensin aldosterone system (RAAS) has a key role in the regulation of blood pressure, ...